A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction

Addiction

Volumn 105, Issue 7, 2010, Pages 1290-1298

  McRobbie, Hayden ^a   Thornley, Simon ^b   Bullen, Chris ^b   Lin, Ruey Bin ^c   Senior, Hugh ^d   Laugesen, Murray ^e   Whittaker, Robyn ^b   Hajek, Peter ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c MACQUARIE UNIVERSITY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Health New Zealand Ltd   (New Zealand)

Author keywords

Craving; Gum; Lozenge; Mouthspray; Nicotine replacement therapy; Pharmacokinetics; Smoking cessation; Tobacco withdrawal

Indexed keywords

NICOTINE; NICOTINIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BUCCAL DRUG ADMINISTRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADMINISTRATION, BUCCAL; ADOLESCENT; ADULT; AGED; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PATIENT SATISFACTION; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953316404     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.02950.x     Document Type: Article

References (22)

1. Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008 1 : CD000146.
2. Killen J. D., Fortmann S. P. Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol 1997 5 : 137 142.
3. Shiffman S., Engberg J. B., Paty J. A., Perz W, G., Gnys M., Kassel, J. D. et al. A day at a time: predicting smoking lapse from daily urge. J Abnorm Psychol 1997 106 : 104 116.
4. Swan G. E., Ward M. M., Jack L. M. Abstinence effects as predictors of 28-day relapse in smokers. Addict Behav 1996 21 : 481 490.
5. Schuh K. J., Schuh L. M., Henningfield J. E., Stitzer M. L. Nicotine nasal spray and vapor inhaler: abuse liability assessment. Psychopharmacology (Berl) 1997 130 : 352 361.
6. Hajek P., West R., Foulds J., Nilsson F., Burrows S., Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med 1999 159 : 2033 2038.
7. Croghan G. A., Sloan J. A., Croghan I. T., Novotny P., Hurt R. D., DeKrey W. L. et al. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine Tob Res 2003 5 : 181 187.
8. Hurt R. D., Offord K. P., Croghan I. T., Croghan G. A., Gomez-Dahl L. C., Wolter T. D. et al. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology (Berl) 1998 140 : 98 104.
9. Park C. R., Munday D. L. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharm 2002 237 : 215 226.
10. Niaura R., Sayette M., Shiffman S., Glover E. D., Nides M., Shelanski M. et al. Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving. Addiction 2005 100 : 1720 1730.
11. Shiffman S., Cone E. J., Buchhalter A. R., Henningfield J. E., Rohay J. M., Gitchell J. G. et al. Rapid absorption of nicotine from new nicotine gum formulations. Pharmacol Biochem Behav 2009 91 : 380 384.
12. Thornley S., McRobbie H., Lin R. B., Bullen C., Hajek P., Laugesen M. et al. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction. Nicotine Tob Res 2009 11 : 715 721.
13. Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerstrom K. O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991 86 : 1119 1127.
14. Hajek P., Belcher M. Improved CO monitors for validating smoking abstinence by expired-air carbon monoxide levels. Br J Addict 1991 86 : 1029 1030.
15. Hughes J. R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986 43 : 289 294.
16. Hughes J., Hatsukami D. K. Errors in using tobacco withdrawal scale. Tob Control 1998 7 : 92 3.
17. Hajek P., Jarvis M. J., Belcher M., Sutherland G., Feyerabend C. Effect of smoke-free cigarettes on 24 h cigarette withdrawal: a double-blind placebo-controlled study. Psychopharmacology (Berl) 1989 97 : 99 102.
18. Feyerabend C., Russell M. A. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 1990 42 : 450 452.
19. Demazieres A., Luthringer R., Coppel E., Gilles C., Fleury C., Roegel J. C. et al. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers. Addict Behav 2006 31 : 537 543.
20. Hurt R. D., Dale L. C., Croghan G. A., Croghan I. T., Gomez-Dahl L. C., Offord K. P. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. Mayo Clin Proc 1998 73 : 118 125.
21. Shiffman S., Gnys M., Richards T. J., Paty J. A., Hickcox M., Kassel J. D. Temptations to smoke after quitting: a comparison of lapsers and maintainers. Health Psychol 1996 15 : 455 461.
22. Ministry of Health. New Zealand Tobacco Use Survey 2006.